Viridian Therapeutics

About:

Viridian Therapeutics focuses in advancing new treatments for patients with diseases that are underserved by today’s therapies.

Website: https://www.viridianbio.com/

Description:

Viridian Therapeutics is a privately held biotechnology company focused on advancing new treatments for patients with diseases that are underserved by today’s therapies.

Total Funding Amount:

$29M

Headquarters Location:

Waltham, Massachusetts, United States

Founded Date:

2019-01-01

Founders:

Jonathan Violin, Vahe Bedian

Number of Employees:

11-50

Last Funding Date:

2020-09-29

IPO Status:

Private

Industries: